Solventum Corp reported $3.66B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Align Technology USD 1.91B 2.74M Jun/2026
Baxter International USD 3.59B 102M Jun/2026
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Cencora USD 56.13B 3B Mar/2026
Dexcom USD 2.36B 133.9M Jun/2026
Insulet USD 744.2M 56.7M Jun/2026
Solventum Corp USD 3.66B 317M Jun/2026
West Pharmaceutical Services USD 640.5M 33.5M Jun/2026
Zimmer Biomet Holdings USD 3.01B 149.2M Jun/2026